Skip to content

Ketamine for addiction: all studies

Page 5 of 14: studies 41 to 50 of 131, newest first. Back to the ketamine for addiction overview

Research

Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity.

Trials April 17, 2025 Arash Mansoori, Amir Bazrafshan, Jamshid Ahmadi et al. 4 citations

The concomitant presence of major depressive disorder (MDD) and opioid use disorder (OUD) poses a formidable clinical challenge, warranting effective interventions that address both psychiatric and addictive components. This study sought to compare the efficacy of adjunctive ketamine and buprenorphine in mitigating anxiety symptom severity and craving intensity in individuals with co-occurring...

Rare but relevant: Ketamine-induced cystitis - an in-depth review for addiction medicine.

Addiction (Abingdon, England) April 4, 2025 Asem Abdelrahman, Mo Belal 4 citations

Ketamine-induced cystitis is an increasingly recognized complication associated with the addictive use of ketamine, a dissociative anesthetic. This article provides a comprehensive overview, focusing on its pathophysiology, clinical presentation, diagnosis, management strategies, and implications for addiction treatment. The British Association of Urological Surgeons consensus serves as a...

DOI: 10.1111/add.70052 (opens in new tab) Full text (opens in new tab) Ketamine bladder dysfunction Ketamine cystitis Ketamine uropathy Ureteric stricture +6

Ketamine-Assisted Psychotherapy for Addiction: Mechanisms, Evidence, and Clinical Implications

April 1, 2025 Ryan D Ward

Substance use disorders (SUDs) are notoriously difficult to treat due to complex biopsychosocial underpinnings and high relapse rates. Recent evidence positions ketamine-assisted psychotherapy (KAP) as a promising intervention for treatment-resistant addiction. This review explores ketamine’s neurobiological mechanisms, its synergistic effect with psychotherapy, and clinical data supporting its...

Qualitative analysis of a patient's experience of ketamine-assisted psychotherapy for substance use disorder: Empirical synergies with twelve-step programs

Psychiatry Research Case Reports March 24, 2025 Dan Petrovitch, Jacob Spinks, H.J. Yoo et al. 3 citations

Ketamine has demonstrated early promise for treating substance use disorder (SUD). Despite the emerging evidence for ketamine-based approaches for SUD, little has been published on the integration of ketamine-assisted psychotherapy (KAP) with existing pharmacologic, psychosocial, and peer-support approaches to treatment and recovery, including 12-step programs. Here, we present the case of a...

DOI: 10.1016/j.psycr.2025.100259 (opens in new tab) Ketamine Psychotherapist Substance use Empirical research

Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders.

Biological Psychiatry March 15, 2025 Anna Onisiforou, Andria Michael, Markos Apostolakis et al. 14 citations

Opioid use disorder (OUD) has reached epidemic proportions, with many countries facing high levels of opioid use and related fatalities. Although currently prescribed medications for OUD are considered lifesaving, they inadequately address negative affect and cognitive impairment, resulting in high relapse rates to nonmedical opioid use even years after drug cessation (protracted abstinence)....

DOI: 10.1016/j.biopsych.2024.09.008 (opens in new tab) Full text (opens in new tab) Hydroxynorketamine Opioid crisis Opioid use disorders Relapse +4

Breaking the cycle: a systematic review of neurobiological mechanisms and psychotherapeutic innovations in ketamine addiction.

Journal of Addictive Diseases March 6, 2025 Christopher Lomas 2 citations

This systematic review synthesizes current evidence on non-prescribed ketamine use, emphasizing its neurobiological impacts and psychotherapeutic interventions. Patterns of misuse demonstrate the complex interplay of neurobiological, socio-economic, demographic and psychological factors with adolescents, women and polysubstance users identified as high-risk groups. Neurobiological findings...

Neurobiological Mechanisms of Ketamine Use, its Addiction, and Withdrawal: A Mini Review.

Current reviews in clinical and experimental pharmacology March 3, 2025 Sin Hui Ng, Yu Zhao Lee, Ming Ye Hong et al. 2 citations

Ketamine, a substance used for anesthesia and known for inducing dissociation, can lead to addiction and the development of severe withdrawal symptoms. Ketamine alters brain networks before affecting somesthetic sensation. Ketamine abuse was especially prevalent in East and Southeast Asia, and its popularity has continued to expand globally in recent decades. Ketamine is gaining popularity in...

Characterization of Oral Ketamine Use: A Retrospective Review.

Journal of Pain & Palliative Care Pharmacotherapy March 1, 2025 Miranda Hetrick, Emily Casey, Jacob Radcliff et al. 2 citations

Ketamine is an N-methyl D-aspartate (NMDA) receptor antagonist used to treat pain at subanesthetic doses. Ketamine is beneficial for pain control in patients who have a high tolerance to opioids and are experiencing opioid-induced hyperalgesia. This study characterizes oral ketamine use for analgesia at a large academic hospital and reports safety outcomes for hospitalized patients. This study...

Brain acid sphingomyelinase controls addiction-related behaviours in a sex-specific way.

Neurobiology of Disease March 1, 2025 Liubov S. Kalinichenko, Iulia Zoicas, Anne-Marie Bienia et al. 4 citations

Addiction is a chronic and severe mental disorder with high gender- and sex-specificity. However, the pathogenesis of this disorder is not fully elucidated, and no targeted pharmacotherapy is available. A growing body of evidence points out the potential involvement of the ceramide system in the pathophysiology of addiction. A pathogenic pathway for several mental disorders based on the...

Treadmill Exercise Training Ameliorates Apoptotic Cells and DNA Oxidation in the Cerebral Cortex of Rats Exposed to Chronic Ketamine Abuse.

Addiction Biology March 1, 2025 Salar Sabziparvar, Kazem Khodaei, Javad Tolouei Azar 1 citation

Ketamine abuse damages brain function and structure, increasing reactive oxygen species and apoptosis in the cerebral cortex, but moderate-intensity continuous training (MICT) can enhance antioxidant defences and reduce apoptosis. Therefore, we aimed to answer whether MICT can reduce the side effects of chronic ketamine abuse. 24 Wistar rats were split into control (CON), ketamine abuse (KET),...